SCIO-469 Scios Inc
Nikas, S.N.; Drosos, A.A.
Current Opinion in Investigational Drugs 5(11): 1205-1212
2004
ISSN/ISBN: 1472-4472 PMID: 15573872 Document Number: 569346
SCIO-469 is a small-molecule p38 mitogen-activated protein (MAP) kinase inhibitor under development by Scios Inc as a potential oral therapy for inflammatory disorders. By July 2004, SCIO-469 was in phase lib clinical trials for rheumatoid arthritis.